Zhilin Li - 09 Sep 2021 Form 4 Insider Report for CHINA PHARMA HOLDINGS, INC. (CPHI)

Role
CEO & Interim CFO, Director, 10%+ Owner
Signature
By: /s/ Zhilin Li
Issuer symbol
CPHI
Transactions as of
09 Sep 2021
Net transactions value
+$1,179,200
Form type
4
Filing time
13 Sep 2021, 21:19:38 UTC
Next filing
19 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPHI Common Stock Award $1,179,200 +1,760,000 +15% $0.6700 13,810,000 09 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 9, 2021, the reporting person was granted 1,760,000 shares of Issuer's common stock under the Issuer's 2010 Long-Term Incentive Plan, vesting immediately with no restrictions, as partial offset of her accrued but unpaid cash compensation by serving as the Issuer's Chairman of the Board, Chief Executive Officer and interim Chief Financial Officer.